Stimulation of glucose uptake by theasinensins through the AMP-activated protein kinase pathway in rat skeletal muscle cells

Ju Qiu, Kanako Maekawa, Yuko Kitamura, Yuji Miyata, Kazunari Tanaka, Takashi Tanaka, Minoru Soga, Takanori Tsuda, Toshiro Matsui

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Theasinensins, dimeric catechins, have been reported to possess anti-hyperglycemic activity, but the underlying mechanism for this activity remains unknown. In this study, the effect of theasinensins A and B on glucose uptake into rat skeletal muscle cells (L6 myotubes) was investigated. A glucose uptake study using 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose (2-NBDG) indicated that both theasinensins A and B stimulated glucose uptake in a concentration-dependent manner and translocation of glucose transporter 4 (GLUT4) to the plasma membrane. In addition, inhibition studies measuring 2-NBDG uptake in L6 cells revealed that compound C (AMP-activated protein kinase inhibitor) suppressed theasinensin-stimulated glucose uptake, whereas genistein (insulin receptor tyrosine kinase inhibitor) and wortmannin (phosphatidylinositol 3-kinase inhibitor) were inactive. Subsequent experiments on GLUT4-related signaling pathways in L6 cells demonstrated that theasinensins promoted the phosphorylation of AMPK, but not that of Akt, and that the theasinensin-promoted glucose uptake was blocked in the presence of a CaMKK inhibitor. The promotion of AMPK phosphorylation by theasinensins was not blocked in LKB1-knockdown cells. Consequently, it was concluded that theasinensins A and B did in fact promote GLUT4 translocation to the plasma membrane in L6 myotubes through the CaMKK/AMPK signaling pathway, but not through the PI3K/Akt pathway.

Original languageEnglish
Pages (from-to)344-351
Number of pages8
JournalBiochemical Pharmacology
Volume87
Issue number2
DOIs
Publication statusPublished - Jan 15 2014

Fingerprint

AMP-Activated Protein Kinases
Muscle Cells
Muscle
Rats
Skeletal Muscle
Cells
Facilitative Glucose Transport Proteins
Calcium-Calmodulin-Dependent Protein Kinase Kinase
Glucose
Phosphorylation
Skeletal Muscle Fibers
Cell membranes
Cell Membrane
Phosphatidylinositol 3-Kinase
Catechin
Genistein
Protein Kinase Inhibitors
Phosphatidylinositol 3-Kinases
theasinensin A
epigallocatechin-3-O-gallate epigallocatechin dimer

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Pharmacology

Cite this

Stimulation of glucose uptake by theasinensins through the AMP-activated protein kinase pathway in rat skeletal muscle cells. / Qiu, Ju; Maekawa, Kanako; Kitamura, Yuko; Miyata, Yuji; Tanaka, Kazunari; Tanaka, Takashi; Soga, Minoru; Tsuda, Takanori; Matsui, Toshiro.

In: Biochemical Pharmacology, Vol. 87, No. 2, 15.01.2014, p. 344-351.

Research output: Contribution to journalArticle

Qiu, Ju ; Maekawa, Kanako ; Kitamura, Yuko ; Miyata, Yuji ; Tanaka, Kazunari ; Tanaka, Takashi ; Soga, Minoru ; Tsuda, Takanori ; Matsui, Toshiro. / Stimulation of glucose uptake by theasinensins through the AMP-activated protein kinase pathway in rat skeletal muscle cells. In: Biochemical Pharmacology. 2014 ; Vol. 87, No. 2. pp. 344-351.
@article{2544d295a0c74638832ac9b0e700a381,
title = "Stimulation of glucose uptake by theasinensins through the AMP-activated protein kinase pathway in rat skeletal muscle cells",
abstract = "Theasinensins, dimeric catechins, have been reported to possess anti-hyperglycemic activity, but the underlying mechanism for this activity remains unknown. In this study, the effect of theasinensins A and B on glucose uptake into rat skeletal muscle cells (L6 myotubes) was investigated. A glucose uptake study using 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose (2-NBDG) indicated that both theasinensins A and B stimulated glucose uptake in a concentration-dependent manner and translocation of glucose transporter 4 (GLUT4) to the plasma membrane. In addition, inhibition studies measuring 2-NBDG uptake in L6 cells revealed that compound C (AMP-activated protein kinase inhibitor) suppressed theasinensin-stimulated glucose uptake, whereas genistein (insulin receptor tyrosine kinase inhibitor) and wortmannin (phosphatidylinositol 3-kinase inhibitor) were inactive. Subsequent experiments on GLUT4-related signaling pathways in L6 cells demonstrated that theasinensins promoted the phosphorylation of AMPK, but not that of Akt, and that the theasinensin-promoted glucose uptake was blocked in the presence of a CaMKK inhibitor. The promotion of AMPK phosphorylation by theasinensins was not blocked in LKB1-knockdown cells. Consequently, it was concluded that theasinensins A and B did in fact promote GLUT4 translocation to the plasma membrane in L6 myotubes through the CaMKK/AMPK signaling pathway, but not through the PI3K/Akt pathway.",
author = "Ju Qiu and Kanako Maekawa and Yuko Kitamura and Yuji Miyata and Kazunari Tanaka and Takashi Tanaka and Minoru Soga and Takanori Tsuda and Toshiro Matsui",
year = "2014",
month = "1",
day = "15",
doi = "10.1016/j.bcp.2013.10.029",
language = "English",
volume = "87",
pages = "344--351",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Stimulation of glucose uptake by theasinensins through the AMP-activated protein kinase pathway in rat skeletal muscle cells

AU - Qiu, Ju

AU - Maekawa, Kanako

AU - Kitamura, Yuko

AU - Miyata, Yuji

AU - Tanaka, Kazunari

AU - Tanaka, Takashi

AU - Soga, Minoru

AU - Tsuda, Takanori

AU - Matsui, Toshiro

PY - 2014/1/15

Y1 - 2014/1/15

N2 - Theasinensins, dimeric catechins, have been reported to possess anti-hyperglycemic activity, but the underlying mechanism for this activity remains unknown. In this study, the effect of theasinensins A and B on glucose uptake into rat skeletal muscle cells (L6 myotubes) was investigated. A glucose uptake study using 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose (2-NBDG) indicated that both theasinensins A and B stimulated glucose uptake in a concentration-dependent manner and translocation of glucose transporter 4 (GLUT4) to the plasma membrane. In addition, inhibition studies measuring 2-NBDG uptake in L6 cells revealed that compound C (AMP-activated protein kinase inhibitor) suppressed theasinensin-stimulated glucose uptake, whereas genistein (insulin receptor tyrosine kinase inhibitor) and wortmannin (phosphatidylinositol 3-kinase inhibitor) were inactive. Subsequent experiments on GLUT4-related signaling pathways in L6 cells demonstrated that theasinensins promoted the phosphorylation of AMPK, but not that of Akt, and that the theasinensin-promoted glucose uptake was blocked in the presence of a CaMKK inhibitor. The promotion of AMPK phosphorylation by theasinensins was not blocked in LKB1-knockdown cells. Consequently, it was concluded that theasinensins A and B did in fact promote GLUT4 translocation to the plasma membrane in L6 myotubes through the CaMKK/AMPK signaling pathway, but not through the PI3K/Akt pathway.

AB - Theasinensins, dimeric catechins, have been reported to possess anti-hyperglycemic activity, but the underlying mechanism for this activity remains unknown. In this study, the effect of theasinensins A and B on glucose uptake into rat skeletal muscle cells (L6 myotubes) was investigated. A glucose uptake study using 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose (2-NBDG) indicated that both theasinensins A and B stimulated glucose uptake in a concentration-dependent manner and translocation of glucose transporter 4 (GLUT4) to the plasma membrane. In addition, inhibition studies measuring 2-NBDG uptake in L6 cells revealed that compound C (AMP-activated protein kinase inhibitor) suppressed theasinensin-stimulated glucose uptake, whereas genistein (insulin receptor tyrosine kinase inhibitor) and wortmannin (phosphatidylinositol 3-kinase inhibitor) were inactive. Subsequent experiments on GLUT4-related signaling pathways in L6 cells demonstrated that theasinensins promoted the phosphorylation of AMPK, but not that of Akt, and that the theasinensin-promoted glucose uptake was blocked in the presence of a CaMKK inhibitor. The promotion of AMPK phosphorylation by theasinensins was not blocked in LKB1-knockdown cells. Consequently, it was concluded that theasinensins A and B did in fact promote GLUT4 translocation to the plasma membrane in L6 myotubes through the CaMKK/AMPK signaling pathway, but not through the PI3K/Akt pathway.

UR - http://www.scopus.com/inward/record.url?scp=84892367429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892367429&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2013.10.029

DO - 10.1016/j.bcp.2013.10.029

M3 - Article

C2 - 24225153

AN - SCOPUS:84892367429

VL - 87

SP - 344

EP - 351

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 2

ER -